Insulet Corp. (PODD)
294.62
-0.57
(-0.19%)
USD |
NASDAQ |
Dec 11, 16:00
294.62
0.00 (0.00%)
After-Hours: 17:54
Insulet Research and Development Expense (TTM): 270.80M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| ResMed, Inc. | 339.08M |
| Baxter International, Inc. | 518.00M |
| Tandem Diabetes Care, Inc. | 198.42M |
| Masimo Corp. | 172.00M |